Cariprazine and clozapine combination for the treatment of psychosis in a young, female patient with schizophrenia: a case report

The task of a psychiatrist is to select the most appropriate medication or combination of drugs to treat the symptoms of schizophrenia while minimizing the risk of side effects and ensuring the patient achieves the highest level of functioning possible. This is a challenging task as the action of each drug or group of drugs is different. The efficacy of cariprazine, which affects D3 receptors as a D3/D2 receptor partial agonist, has been extensively studied and is one of the first medication choices by practicing psychiatrists when treating patients with negative symptomatology. In this clinical case, we demonstrate the effective and safe treatment of a patient's positive and affective symptoms using a combination of cariprazine, clozapine, and venlafaxine.

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2024-08-21
DOI
https://doi.org/10.3389/fpsyt.2024.1452980
Citations
5
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
1.93
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cariprazine and clozapine combination for the treatment of psychosis in a young, female patient with schizophrenia: a case report

Māris Taube, Anzejs Dmuhovskis
5 citations
Frontiers in Psychiatry
Schizophrenia research and treatment
1.93
article

Cariprazine and clozapine combination for the treatment of psychosis in a young, female patient with schizophrenia: a case report

Māris Taube, Anzejs Dmuhovskis
article en
5 citations

Abstract

The task of a psychiatrist is to select the most appropriate medication or combination of drugs to treat the symptoms of schizophrenia while minimizing the risk of side effects and ensuring the patient achieves the highest level of functioning possible. This is a challenging task as the action of each drug or group of drugs is different. The efficacy of cariprazine, which affects D3 receptors as a D3/D2 receptor partial agonist, has been extensively studied and is one of the first medication choices by practicing psychiatrists when treating patients with negative symptomatology. In this clinical case, we demonstrate the effective and safe treatment of a patient's positive and affective symptoms using a combination of cariprazine, clozapine, and venlafaxine.

Frontiers in PsychiatryVol. 15
Riga Stradiņš University (LV)
Good health and well-being
Openalex Percentile: Top 13%
Schizophrenia research and treatment
1.93
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.